Korostin Dmitriy Olegovich

Korostin Dmitriy Olegovich

Auto-generated profile, based on publicly available information

Korostin Dmitriy Olegovich

Genotek Ltd, Nastavnicheskii pereulok 17/1, 105120 Moscow, Russia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2019 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
KBKondakova Olga Borisovna
Kondakova Olga Borisovna
KYKrasnenko Anna Yurievna
Krasnenko Anna Yurievna
TYTsukanov Kirill Yurievich
Tsukanov Kirill Yurievich
KIKlimchuk Olesya Igorevna
Klimchuk Olesya Igorevna
KOKorostin Dmitriy Olegovich
Korostin Dmitriy Olegovich
VIValery Ilinsky
Valery Ilinsky
Dystroglycanopathies, which are caused by reduced glycosylation of alpha-dystroglycan, are a heterogeneous group of neurodegenerative disorders characterized by variable brain and skeletal muscle involvement. Muscle-eye-brain disease (or muscular dystrophy-dystroglycanopathy type 3 A) is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities, and lissencephaly. We report clinical and genetic characteristics of a 6-year-old boy affected by muscular dystrophy-dystroglycanopathy. He has severe a delay in psychomotor and speech development, muscle hypotony, congenital myopia, partial atrophy of the optic nerve disc, increased level of creatine kinase, primary-muscle lesion, polymicrogyria, ventriculomegaly, hypoplasia of the corpus callosum, cysts of the cerebellum. Exome sequencing revealed compound heterozygous mutations in POMGNT1 gene (transcript NM_001243766.1): c.1539 + 1G > A and c.385C > T. The present case report shows diagnostic algorithm step by step and helps better understand the clinical and genetic features of congenital muscular dystrophy.